Last reviewed · How we verify

NCT06715384: CAM

Evaluation of a CAM System for Colorectal Polyp Size Measurement

Recruiting now NA Last updated 19 February 2025
What this trial tests

NA trial testing Polyp size measurement using autonomous AI measurement or AI-assisted human measurement with the CAM system in Colorectal Polyp in 168 participants. Currently enrolling.

Timeline
15 December 2024
Primary endpoint
1 April 2025
30 April 2025

Quick facts

Lead sponsorChanghai Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingsingle
Primary purposediagnostic
Enrollment168
Start date15 December 2024
Primary completion1 April 2025
Estimated completion30 April 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Changhai Hospital

Who can join

Adults 18 to 85, any sex, with Colorectal Polyp or Colorectal Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Accurate polyp size measurements are essential for risk stratification, selection of polypectomy techniques, and surveillance interval assignments. Evidence indicated that the clinical implementation of artificial intelligence is an optimal tool to improve the measurement of polyps during colonoscopy. This study aimed to evaluate the performance of a computer-aided measuring (CAM) system (EndoDASS) and compare its accuracy with routine sizing methods during real-time colonoscopy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Colorectal Polyp

Currently open trials in the same condition.

Other Changhai Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06715384.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing